Chlamidia Antibodies Test for Tubal Factor Screening

Instituto Valenciano de Infertilidad, IVI VALENCIA60 enrolled

Overview

The aim of this study is to evaluate the usefulness of a Chlamydia Antibody Test for screening of tubal factor in patients who undergo artificial insemination.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Sterility

Interventions

CAT testOTHER

A CAT test is performed in order to diagnose tubal factor causes

HisterosalpingographyOTHER

A Histerosalpingography is performed.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 38 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age \< 38 years * FSH \< 12. * Treatment intrauterine insemination Exclusion Criteria: * Insulin dependent diabetes * Thyroid disease * Severe male factor * Policystic ovarian syndrome * Previous abdominal or uterine surgery * Prevous abdominal or genital infections * Uterine myomas * Hidrosalpinx * Uterine congenital abnormalities

Locations (1)

IVI Valencia

Valencia, Spain

Outcomes

Primary Outcomes

Pregnancy outcome using the two different treatments.

Pregnancy rate, cumulative pregnancy rate and ectopic pregnancy rate in order to evaluate de usefulness of the CAT test as a predictor of tubal pathology.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.